Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck

The combination of nab-paclitaxel, CbP and C225 is feasible, tolerable and active against locally advanced SCCHN.